Literature DB >> 9414330

Quinidine.

A A Grace1, A J Camm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9414330     DOI： 10.1056/NEJM199801013380107

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  25 in total

1.  Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline.

Authors:  A G Teschemacher; E P Seward; J C Hancox; H J Witchel
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

2.  Randomized open-label drug-drug interaction trial of dextromethorphan/quinidine and paroxetine in healthy volunteers.

Authors:  Kerri A Schoedel; Laura E Pope; Edward M Sellers
Journal:  Clin Drug Investig       Date:  2012-03-01       Impact factor: 2.859

3.  A rabbit Langendorff heart proarrhythmia model: predictive value for clinical identification of Torsades de Pointes.

Authors:  C L Lawrence; M H Bridgland-Taylor; C E Pollard; T G Hammond; J-P Valentin
Journal:  Br J Pharmacol       Date:  2006-10-09       Impact factor: 8.739

Review 4.  Cardiac complications of unwitting co-injection of quinine/quinidine with heroin in an intravenous drug user.

Authors:  Karran A Phillips; Glenn A Hirsch; David H Epstein; Kenzie L Preston
Journal:  J Gen Intern Med       Date:  2012-05-17       Impact factor: 5.128

5.  Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels.

Authors:  Menghang Xia; Sampada A Shahane; Ruili Huang; Steven A Titus; Enoch Shum; Yong Zhao; Noel Southall; Wei Zheng; Kristine L Witt; Raymond R Tice; Christopher P Austin
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-26       Impact factor: 4.219

6.  Mechanisms of artemether toxicity on single cardiomyocytes and protective effect of nanoencapsulation.

Authors:  Ana Carolina Moreira Souza; Andrea Grabe-Guimarães; Jader Dos Santos Cruz; Artur Santos-Miranda; Charlotte Farah; Liliam Teixeira Oliveira; Alexandre Lucas; Franck Aimond; Pierre Sicard; Vanessa Carla Furtado Mosqueira; Sylvain Richard
Journal:  Br J Pharmacol       Date:  2020-08-24       Impact factor: 8.739

7.  Treatment Responsiveness in KCNT1-Related Epilepsy.

Authors:  Mark P Fitzgerald; Martina Fiannacca; Douglas M Smith; Tracy S Gertler; Boudewijn Gunning; Steffen Syrbe; Nienke Verbeek; Hannah Stamberger; Sarah Weckhuysen; Berten Ceulemans; An-Sofie Schoonjans; Massimiliano Rossi; Geneviève Demarquay; Gaetan Lesca; Kern Olofsson; D A Koolen; Frauke Hornemann; Stephanie Baulac; Guido Rubboli; Kelly Q Minks; Bohoon Lee; Ingo Helbig; Dennis Dlugos; Rikke S Møller; David Bearden
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

8.  Severe Malaria Complicated by G6PD Deficiency in a Pediatric Tanzanian Immigrant.

Authors:  Heather N Damhoff; Robert J Kuhn; Laura P Stadler
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

9.  Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1.

Authors:  Hongli Shan; Xuelian Li; Zhenwei Pan; Li Zhang; Benzhi Cai; Yong Zhang; Chaoqian Xu; Wenfeng Chu; Guofen Qiao; Baoxin Li; Yanjie Lu; Baofeng Yang
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

Review 10.  Clinical pharmacokinetics of mibefradil.

Authors:  H A Welker; H Wiltshire; R Bullingham
Journal:  Clin Pharmacokinet       Date:  1998-12       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.